Literature DB >> 15104362

Esophageal bacteria and Barrett's esophagus: a preliminary report.

Glenn L Osias1, Matthew Q Bromer, Rebecca M Thomas, David Friedel, Larry S Miller, Byungse Suh, Bennett Lorber, Henry P Parkman, Robert S Fisher.   

Abstract

The objective of this study was to investigate if esophageal bacteria are associated with Barrett's esophagus (BE). This study was comprised of a retrospective (Part 1) and a subsequent prospective (Part 2) study. In Part 1, Gram stains were performed on esophageal biopsy specimens obtained in 47 patients. Bacteria were quantitated from 0 to 4. In Part 2, Gram stains and cultured bacterial counts of esophageal biopsies were obtained in 18 GERD patients (9 with BE and 9 without BE). Part 1 results were as follows. Bacteria were found in 37 of 47 esophageal biopsies. Quantitative bacterial stain scores for BE (2.5 +/- 0.2) were higher than for non-BE (1.5 +/- 0.3; P = 0.02). The quantitative bacterial stain scores correlated with increasing severity of dysplasia (r = 0.37, P = 0.028). In Part 2, bacteria were found in 8 of 18 esophageal biopsies by Gram stain (6 of 9 patients with BE vs. 2 of 9 non-BE). The distal esophageal bacterial stain scores in BE patients (1.6 +/- 0.5) were higher than in those without BE (0.4 +/- 0.3; P = 0.07). Patients on proton pump inhibitors tended to have higher bacterial stain scores (1.2 +/- 0.4) than patients who were not (0.7 +/- 0.3; P = 0.45). Bacterial colony counts were similar in patients with BE compared to those without BE. In conclusion, bacteria in esophageal biopsies were detected more often in BE than non-BE. Increasing bacterial stain scores were associated with metaplasia and increasing dysplasia. Esophageal bacteria, possibly related to stasis or gastric acid suppression therapy, may play a role in the pathogenesis of BE and dysplasia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104362     DOI: 10.1023/b:ddas.0000017443.44802.4b

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.

Authors:  C Mowat; C Williams; D Gillen; M Hossack; D Gilmour; A Carswell; A Wirz; T Preston; K E McColl
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

3.  Neoplasia after ureterosigmoidostomy.

Authors:  K Azimuddin; I T Khubchandani; J J Stasik; L Rosen; R D Riether
Journal:  Dis Colon Rectum       Date:  1999-12       Impact factor: 4.585

Review 4.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 5.  Bacterial overgrowth of the gastrointestinal tract.

Authors:  P P Toskes
Journal:  Adv Intern Med       Date:  1993

6.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure.

Authors:  S Oberg; T R DeMeester; J H Peters; J A Hagen; J J Nigro; S R DeMeester; J Theisen; G M Campos; P F Crookes
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

7.  Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma.

Authors:  D A Katzka; J C Reynolds; S H Saul; A Plotkin; C A Lang; A Ouyang; S Jimenez; S Cohen
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965

8.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

Authors:  E Verdu; F Viani; D Armstrong; R Fraser; H H Siegrist; B Pignatelli; J P Idström; C Cederberg; A L Blum; M Fried
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

10.  Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?

Authors:  M Coenraad; A A Masclee; J W Straathof; S Ganesh; G Griffioen; C B Lamers
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

View more
  9 in total

Review 1.  Microbiome in reflux disorders and esophageal adenocarcinoma.

Authors:  Liying Yang; Noami Chaudhary; Jonathan Baghdadi; Zhiheng Pei
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

Review 4.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

Review 5.  Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Erik J Snider; Daniel E Freedberg; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

6.  Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.

Authors:  Teminioluwa A Ajayi; Sarah Cantrell; Ashley Spann; Katherine S Garman
Journal:  PLoS Pathog       Date:  2018-12-20       Impact factor: 6.823

7.  Novel device to sample the esophageal microbiome--the esophageal string test.

Authors:  Sophie A Fillon; J Kirk Harris; Brandie D Wagner; Caleb J Kelly; Mark J Stevens; Wendy Moore; Rui Fang; Shauna Schroeder; Joanne C Masterson; Charles E Robertson; Norman R Pace; Steven J Ackerman; Glenn T Furuta
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

Review 8.  Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications.

Authors:  Yoshifumi Baba; Masaaki Iwatsuki; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2017-06-07

Review 9.  Metaplastic Paneth Cells in Extra-Intestinal Mucosal Niche Indicate a Link to Microbiome and Inflammation.

Authors:  Rajbir Singh; Iyshwarya Balasubramanian; Lanjing Zhang; Nan Gao
Journal:  Front Physiol       Date:  2020-03-31       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.